Where is that OB's F***ing Defender?

Quote

Anonymous

Guest
OB is about to cut oncology sales force by 50%. The guy who knows zero about oncology is making decisions about oncology. There will be 2 RSD's (east-west), 10 DMs, and 100 reps. Now where is that fucking LM's basher who gave us OB? I like to fuck that asshole dry. Remember how bad LM was supposed to be and how great OB was supposed to be? Remember all the garbage about LM? Are you happy now you fucker? Is Japan that fucking stupid?
 






And you don't think the cuts would be the same with LM? It doesn't matter who is "in charge", the numbers don't lie. What would she be able to do differently than OB in this instance? LM sucked.
 



LM gave it to us straight. She was far from perfect but at least we knew what we were getting with her. LM or any other real VP of sales would never accept these draconian cuts in the sales force for oncology. The revenue for the oncology is not being reduced drastically. OB knows shit about oncology. He wants oncology to subsidize his mistakes in primary care. By the way, wasn't OB supposed to be better anyway? Is the current situation better for us than last year?
 






Anonymous said:
Why do I need Oncology knowledge to make a business decision??????

I am not OB.
Click to expand...

A business decision about oncology's market requires understanding of the market place, clients' needs, and resource management needed to meet the customers' needs. You just don't cut the sales force by 50% if your revenue stayed the same. The reps are already busting their tails every day in this difficult market. Eisai does not have the best products to begin with and it requires a lot of work to sell Eisai's products. OB is not qualified to make such a decision.
 



Anonymous said:
OB is about to cut oncology sales force by 50%. The guy who knows zero about oncology is making decisions about oncology. There will be 2 RSD's (east-west), 10 DMs, and 100 reps. Now where is that fucking LM's basher who gave us OB? I like to fuck that asshole dry. Remember how bad LM was supposed to be and how great OB was supposed to be? Remember all the garbage about LM? Are you happy now you fucker? Is Japan that fucking stupid?
Click to expand...

Three brands that Eisai was counting on were not approved. How is this OB's fault?
 



Was it a surprise? What was the contingency plan by OB? How much revenue were we estimating for the brands and was it even realistic? Were they all oncology related? Who devised the staffing plan for the past year? Why did Keith W resign? What was his disagreement with OB?
 



Anonymous said:
Three brands that Eisai was counting on were not approved. How is this OB's fault?
Click to expand...

Bringing in new hires was something that could have been controlled and put on freeze until the information from the FDA came in. This would have kept the current reps with better opportunities to keep positions here rather than be forced to look elsewhere. Most companies do not bring in new hires until the FDA approves the products.
 



Anonymous said:
Bringing in new hires was something that could have been controlled and put on freeze until the information from the FDA came in. This would have kept the current reps with better opportunities to keep positions here rather than be forced to look elsewhere. Most companies do not bring in new hires until the FDA approves the products.
Click to expand...

He blew it.
 



Anonymous said:
Bringing in new hires was something that could have been controlled and put on freeze until the information from the FDA came in. This would have kept the current reps with better opportunities to keep positions here rather than be forced to look elsewhere. Most companies do not bring in new hires until the FDA approves the products.
Click to expand...

You are absolutely wrong about that. Pharma companies do not wait until approval to start all the hiring and training. You do all that pre-approval so you're ready to go on day 1. Someone in HO did sell LC on the high likelyhood of approval though. Or maybe they didn't and LC is just not that bright. I'm going with option 2.
 



Anonymous said:
A business decision about oncology's market requires understanding of the market place, clients' needs, and resource management needed to meet the customers' needs. You just don't cut the sales force by 50% if your revenue stayed the same. The reps are already busting their tails every day in this difficult market. Eisai does not have the best products to begin with and it requires a lot of work to sell Eisai's products. OB is not qualified to make such a decision.
Click to expand...

Ok. Then you tell me who the f*&$ is qualified? Seriously? None of these mutha f'ers know their ass from their elbow.
 



Anonymous said:
You are absolutely wrong about that. Pharma companies do not wait until approval to start all the hiring and training. You do all that pre-approval so you're ready to go on day 1. Someone in HO did sell LC on the high likelyhood of approval though. Or maybe they didn't and LC is just not that bright. I'm going with option 2.
Click to expand...

Contingency offers are given to Sales Reps. You are hired contingent upon drug x getting FDA approval.

This is normal protocol.
 



OB is not at fault the products didn't get approved. What would LM have done? The plans were put in place awhile ago by McKenzie. The decision "tree" was shown by LC on the town hall. IF product A gets approval, you need this many reps. IF product B gets approval, you need this many. IF they DON'T get approved, you need this many. Etc, etc. LM is part of the problem. She changed Eisai to the SFE. LOL. Biggest mistake I have ever seen in my pharma career. This destroyed Oncology and put us 2 years backwards. We never needed seperate Onc and Hospital teams. I could have told you Eritorin would NEVER get approved years ago. What a joke.
 



Anonymous said:
OB is not at fault the products didn't get approved. What would LM have done? The plans were put in place awhile ago by McKenzie. The decision "tree" was shown by LC on the town hall. IF product A gets approval, you need this many reps. IF product B gets approval, you need this many. IF they DON'T get approved, you need this many. Etc, etc. LM is part of the problem. She changed Eisai to the SFE. LOL. Biggest mistake I have ever seen in my pharma career. This destroyed Oncology and put us 2 years backwards. We never needed seperate Onc and Hospital teams. I could have told you Eritorin would NEVER get approved years ago. What a joke.
Click to expand...

I can't believe the decision tree didn't have the following branch on it:
If Eritorin does not get approved
and
If Lorcaserin does not get approved
and
If Aciphex ER does not get approved
and
If Aricept 23mg sales are slow
then
throw LC out on his ass.
 









Anonymous said:
You are absolutely wrong about that. Pharma companies do not wait until approval to start all the hiring and training. You do all that pre-approval so you're ready to go on day 1. Someone in HO did sell LC on the high likelyhood of approval though. Or maybe they didn't and LC is just not that bright. I'm going with option 2.
Click to expand...

When OB and SS decided to bring new sales reps on board before the approval of the new drugs, there were many in the HO who laughed and rolled their eyes in disbelief. They did not object vocally because of the intimidation campaign by OB and SS fully supported by LC. By the way, in fairness to LM, I recall that she resisted hiring new sales reps until the status of the drugs were known. SS and OB were the ones who "sold LC on the high likelyhood of approval". Even if those drugs were approved, we did not need this many new hires because the expected revenue for the new drugs were much smaller than we were lead to believe by OB, SS, and marketing.
 



Anonymous said:
OB is not at fault the products didn't get approved. What would LM have done? The plans were put in place awhile ago by McKenzie. The decision "tree" was shown by LC on the town hall. IF product A gets approval, you need this many reps. IF product B gets approval, you need this many. IF they DON'T get approved, you need this many. Etc, etc. LM is part of the problem. She changed Eisai to the SFE. LOL. Biggest mistake I have ever seen in my pharma career. This destroyed Oncology and put us 2 years backwards. We never needed seperate Onc and Hospital teams. I could have told you Eritorin would NEVER get approved years ago. What a joke.
Click to expand...

It is never OB's fault! It is always someone else. Those of us who know OB for years are used to this excuse.It is not OB's fault that the drugs did not get approved but it is his fault that he did not devise a staffing plan for the worst case scenarios. It was OB's fault that he hired many new reps before the approval of the drugs. OB used McKenzie more than anyone else in this company and somehow he forgets that. The LC's town hall presentation was an excuse for him to pass the blame to someone else. When CS was here, she used to be abrasive but at least she was firm and would say no to BS. If SFE was that bad, then why did OB use it?
 



CS and SS are one in the same. Tried to carry around big stick in this company and got hit in the head like they should have. Always talking down to the reps at meetings like their shit didn't stink. Well I bet it does now that they are on bread and water biooooootches!!!
 



Top Bottom
Back
Quote